| PERIOD ENDING | 30-Nov-08 | 30-Nov-07 | 30-Nov-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue | 2,917 | 11,870 |
-
| | | Gross Profit | (2,917) | (11,870) |
-
| | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,925 | 4,740 | 12,214 | | Non Recurring |
-
|
-
|
-
| | Others | 17 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (5,859) | (16,610) | (12,214) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 620 | 1,414 | 696 | | Earnings Before Interest And Taxes | (5,239) | (15,196) | (11,518) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (5,239) | (15,196) | (11,518) | | Income Tax Expense |
-
| (258) |
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,239) | (14,938) | (11,518) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (5,239) | (14,938) | (11,518) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,239) | ($14,938) | ($11,518) |
|
0.29% Nasdaq 
Income Statement
